Home/Pipeline/Prescription Generics Portfolio

Prescription Generics Portfolio

Various chronic & acute diseases

Approved/CommercialMarketed

Key Facts

Indication
Various chronic & acute diseases
Phase
Approved/Commercial
Status
Marketed
Company

About Genomma Lab Internacional

Genomma Lab Internacional is a major Latin American player in the pharmaceutical and personal care sectors, operating through a diversified brand portfolio that addresses consumer health and wellness needs. The company's strategy focuses on brand-building, strategic acquisitions, and expanding its geographic footprint, particularly in Mexico and the United States. As a publicly listed entity, it has demonstrated consistent growth by capitalizing on its strong distribution channels and deep understanding of regional consumer markets. Its operations span OTC pharmaceuticals, prescription generics, dermocosmetics, and personal care items.

View full company profile